Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

665 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of Impetigo and Antimicrobial Resistance.
Schachner LA, Lynde CW, Kircik LH, Torrelo A, Hohl D, Kwong P, Oza V, Andriessen A, Hebert AA. Schachner LA, et al. Among authors: kwong p. J Drugs Dermatol. 2021 Apr 1;20(4):366-372. doi: 10.36849/JDD.2021.5795. J Drugs Dermatol. 2021. PMID: 33852242 Review.
Consensus on Neonatal Through Preadolescent Acne.
Schachner LA, Eichenfield L, Andriessen A, Benjamin L, Cohen B, Ghali F, Gonzalez M, Hebert A, Kwong P. Schachner LA, et al. Among authors: kwong p. J Drugs Dermatol. 2020 Jun 1;19(6):592-600. doi: 10.36849/JDD.2020.5065. J Drugs Dermatol. 2020. PMID: 32574026
Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Moderate to Severe Atopic Dermatitis in Adults and Children Down to 2 Years of Age in the Pivotal Phase 3 ADORING Trials.
Silverberg JI, Eichenfield LF, Hebert AA, Simpson EL, Stein Gold L, Bissonnette R, Papp KA, Browning J, Kwong P, Korman NJ, Brown PM, Rubenstein DS, Piscitelli SC, Somerville MC, Tallman AM, Kircik L. Silverberg JI, et al. Among authors: kwong p. J Am Acad Dermatol. 2024 May 20:S0190-9622(24)00755-2. doi: 10.1016/j.jaad.2024.05.023. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38777187 Free article.
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial.
Paller AS, Seyger MMB, Magariños GA, Pinter A, Cather JC, Rodriguez-Capriles C, Zhu D, Somani N, Garrelts A, Papp KA; IXORA-PEDS Investigators. Paller AS, et al. JAMA Dermatol. 2022 May 1;158(5):533-541. doi: 10.1001/jamadermatol.2022.0655. JAMA Dermatol. 2022. PMID: 35416908 Free PMC article. Clinical Trial.
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
665 results